| pubmed-article:16171852 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:16171852 | lifeskim:mentions | umls-concept:C1140680 | lld:lifeskim |
| pubmed-article:16171852 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:16171852 | lifeskim:mentions | umls-concept:C0087111 | lld:lifeskim |
| pubmed-article:16171852 | lifeskim:mentions | umls-concept:C0439590 | lld:lifeskim |
| pubmed-article:16171852 | lifeskim:mentions | umls-concept:C0205171 | lld:lifeskim |
| pubmed-article:16171852 | lifeskim:mentions | umls-concept:C2756587 | lld:lifeskim |
| pubmed-article:16171852 | pubmed:issue | 1 | lld:pubmed |
| pubmed-article:16171852 | pubmed:dateCreated | 2005-12-21 | lld:pubmed |
| pubmed-article:16171852 | pubmed:abstractText | Women with ovarian cancer who experience disease progression during or within 6 months of first-line treatment with platinum-based anticancer drugs are considered to have platinum-resistant tumors. These patients have an unfavorable prognosis, and they frequently seek complementary and alternative therapies (CAM). Historically, this represents an understudied and underreported component of ovarian cancer treatment. | lld:pubmed |
| pubmed-article:16171852 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16171852 | pubmed:language | eng | lld:pubmed |
| pubmed-article:16171852 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16171852 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:16171852 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16171852 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16171852 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16171852 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16171852 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16171852 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16171852 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16171852 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16171852 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16171852 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16171852 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:16171852 | pubmed:month | Jan | lld:pubmed |
| pubmed-article:16171852 | pubmed:issn | 0090-8258 | lld:pubmed |
| pubmed-article:16171852 | pubmed:author | pubmed-author:SupkoJeffrey... | lld:pubmed |
| pubmed-article:16171852 | pubmed:author | pubmed-author:SeidenMichael... | lld:pubmed |
| pubmed-article:16171852 | pubmed:author | pubmed-author:RocheMariaM | lld:pubmed |
| pubmed-article:16171852 | pubmed:author | pubmed-author:HeXiaoyingX | lld:pubmed |
| pubmed-article:16171852 | pubmed:author | pubmed-author:KleinAmberA | lld:pubmed |
| pubmed-article:16171852 | pubmed:author | pubmed-author:MallettAlliso... | lld:pubmed |
| pubmed-article:16171852 | pubmed:author | pubmed-author:DuskaLindaL | lld:pubmed |
| pubmed-article:16171852 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:16171852 | pubmed:volume | 100 | lld:pubmed |
| pubmed-article:16171852 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:16171852 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:16171852 | pubmed:pagination | 205-9 | lld:pubmed |
| pubmed-article:16171852 | pubmed:dateRevised | 2007-11-14 | lld:pubmed |
| pubmed-article:16171852 | pubmed:meshHeading | pubmed-meshheading:16171852... | lld:pubmed |
| pubmed-article:16171852 | pubmed:meshHeading | pubmed-meshheading:16171852... | lld:pubmed |
| pubmed-article:16171852 | pubmed:meshHeading | pubmed-meshheading:16171852... | lld:pubmed |
| pubmed-article:16171852 | pubmed:meshHeading | pubmed-meshheading:16171852... | lld:pubmed |
| pubmed-article:16171852 | pubmed:meshHeading | pubmed-meshheading:16171852... | lld:pubmed |
| pubmed-article:16171852 | pubmed:meshHeading | pubmed-meshheading:16171852... | lld:pubmed |
| pubmed-article:16171852 | pubmed:meshHeading | pubmed-meshheading:16171852... | lld:pubmed |
| pubmed-article:16171852 | pubmed:meshHeading | pubmed-meshheading:16171852... | lld:pubmed |
| pubmed-article:16171852 | pubmed:meshHeading | pubmed-meshheading:16171852... | lld:pubmed |
| pubmed-article:16171852 | pubmed:meshHeading | pubmed-meshheading:16171852... | lld:pubmed |
| pubmed-article:16171852 | pubmed:meshHeading | pubmed-meshheading:16171852... | lld:pubmed |
| pubmed-article:16171852 | pubmed:meshHeading | pubmed-meshheading:16171852... | lld:pubmed |
| pubmed-article:16171852 | pubmed:meshHeading | pubmed-meshheading:16171852... | lld:pubmed |
| pubmed-article:16171852 | pubmed:meshHeading | pubmed-meshheading:16171852... | lld:pubmed |
| pubmed-article:16171852 | pubmed:meshHeading | pubmed-meshheading:16171852... | lld:pubmed |
| pubmed-article:16171852 | pubmed:meshHeading | pubmed-meshheading:16171852... | lld:pubmed |
| pubmed-article:16171852 | pubmed:year | 2006 | lld:pubmed |
| pubmed-article:16171852 | pubmed:articleTitle | Prolonged stabilization of platinum-resistant ovarian cancer in a single patient consuming a fermented soy therapy. | lld:pubmed |
| pubmed-article:16171852 | pubmed:affiliation | Division of Medical Oncology, Massachusetts General Hospital, Cox 640, 100 Blossom Street, Boston, MA 02114, USA. | lld:pubmed |
| pubmed-article:16171852 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:16171852 | pubmed:publicationType | Case Reports | lld:pubmed |
| pubmed-article:16171852 | pubmed:publicationType | Research Support, N.I.H., Extramural | lld:pubmed |
